Sherif El-Sabbahy, an analyst from Bank of America Securities, maintained the Buy rating on Legence Corp. Class A. The associated price target remains the same with $55.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Sherif El-Sabbahy has given his Buy rating due to a combination of factors related to Legence Corp. Class A’s exposure to powerful, long-duration capital spending cycles. He views Legence as strategically positioned at the crossroads of two major build-outs—pharmaceutical manufacturing reshoring and data center expansion—both of which are driving substantial demand for specialized craft labor and technical services. With a meaningful share of revenue already coming from life sciences, healthcare, data centers, and technology, Legence is seen as a direct beneficiary of ongoing and announced investment commitments by large pharmaceutical firms seeking to expand and localize production capacity.
Sherif El-Sabbahy also notes that recent multi‑billion‑dollar manufacturing investments announced by leading pharma companies, such as Eli Lilly and Johnson & Johnson, reinforce the view that the current capex upcycle has further to run, supporting a strong medium‑term growth outlook for Legence. In his assessment, the company’s SMID‑cap profile, combined with its alignment to the “Go Vocational” theme, offers attractive leverage to this structural demand for skilled labor and complex project execution. Against this supportive backdrop, and with the stock trading below his price objective of $55 per share, he maintains a constructive stance on the shares and reiterates a Buy recommendation.
El-Sabbahy covers the Industrials sector, focusing on stocks such as Quanta Services, Legence Corp. Class A, and WillScot Mobile Mini Holdings. According to TipRanks, El-Sabbahy has an average return of 7.1% and a 47.00% success rate on recommended stocks.
In another report released on January 31, TipRanks – Google also reiterated a Buy rating on the stock with a $52.00 price target.